Literature DB >> 20429777

Famciclovir: a focus on efficacy and safety.

Samira Mubareka1, Victor Leung, Fred Y Aoki, Donald C Vinh.   

Abstract

IMPORTANCE OF THE FIELD: Famciclovir is the prodrug of penciclovir, a guanosine analogue that inhibits viruses of the alpha sub-family of the Herpesviridae, as well as hepatitis B virus. It is indicated for management of mucocutaneous herpes simplex virus disease and acute herpes zoster, and has been investigated for management of hepatitis B virus infection. AREAS COVERED IN THIS REVIEW: Data for this review were identified by searches of papers published in English on Medline and Scopus, spanning the years 1975 through 1 February 2010 with the key words: 'famciclovir', 'famvir', 'penciclovir', 'herpes', 'oral', 'genital', 'varicella', 'zoster' and 'virus' in association with 'safety', 'toxicity', 'tolerability', 'efficacy' and 'indications'. Relevant references were also obtained from articles acquired through the search strategy. WHAT THE READER WILL GAIN: Readers are also provided with up-to-date information on the use of famciclovir for infections due to herpes simplex, varicella zoster and hepatitis B viruses. Clinical data pertaining to the safety and tolerability of famciclovir are also reviewed. TAKE HOME MESSAGE: Famciclovir is a safe, convenient, and well-tolerated drug when used for its approved indications. The most common side effects indicated in the majority of studies were headache and nausea. Data for its use in childhood and pregnancy are limited.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429777     DOI: 10.1517/14740338.2010.485189

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  4 in total

Review 1.  Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

2.  Clinical characteristics and outcomes of varicella zoster virus infection in children with hematologic malignancies in the acyclovir era.

Authors:  Seul-Ki Kim; Min Chae Kim; Seung Beom Han; Seong Koo Kim; Jae Wook Lee; Nack-Gyun Chung; Bin Cho; Dae Chul Jeong; Jin Han Kang; Hack-Ki Kim
Journal:  Blood Res       Date:  2016-12-23

Review 3.  Experimental Pharmacotherapy for COVID-19: The Latest Advances.

Authors:  Pasquale Pagliano; Giuliana Scarpati; Carmine Sellitto; Valeria Conti; Anna Maria Spera; Tiziana Ascione; Ornella Piazza; Amelia Filippelli
Journal:  J Exp Pharmacol       Date:  2021-01-07

Review 4.  Effectiveness comparisons of antiviral treatments for Bell palsy: a systematic review and network meta-analysis.

Authors:  Jiajie Cao; Xinyue Zhang; Zhiming Wang
Journal:  J Neurol       Date:  2021-03-05       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.